Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spike-antibody responses to COVID-19 vaccination by demographic and clinical factors in a prospective community cohort study
Madhumita Shrotri, Ellen Fragaszy, Vincent Nguyen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity
Ho Yu Ng, Wai K. Leung, Ka Shing Cheung
Microorganisms (2023) Vol. 11, Iss. 2, pp. 452-452
Open Access | Times Cited: 21
Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study
John S. Kim, Yifei Sun, Pallavi Balte, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
­­Evaluating blood sampling strategies within the SIREN study: the experience from a large cohort of healthcare workers in the UK
Nipunadi Hettiarachchi, Debbie Blick, Tom Coleman, et al.
Research Square (Research Square) (2025)
Open Access
The Effect of HLA Polymorphism on Immune Response to SARS‐CoV‐2 Vaccination Within an Infection‐Naïve, Vulnerable Population With End‐Stage Renal Disease
F. Shinewi May Erskine, Katrina Spensley, Maria Prendecki, et al.
HLA (2025) Vol. 105, Iss. 2
Open Access
An institutional COVID-19 initiative: creation of a biobank and serological data analysis in pre- and post-vaccination cohorts
Lorena O. Fernandes-Siqueira, Renato Melo, Luciana S. Wermelinger, et al.
Anais da Academia Brasileira de Ciências (2025) Vol. 97, Iss. 1
Open Access
Post COVID-19 vaccination binding and neutralizing antibody with or without previous infection: An 18-month longitudinal study in Indonesia
Tonang Dwi Ardyanto, Khariri Khariri, Telly Purnamasari Agus, et al.
Narra J (2024) Vol. 4, Iss. 2, pp. e1071-e1071
Open Access | Times Cited: 3
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies
James Hollister, Alberto J. Caban‐Martinez, Katherine Ellingson, et al.
Environmental Research (2023) Vol. 239, pp. 117297-117297
Open Access | Times Cited: 9
Low antibody levels associated with significantly increased rate of SARS‐CoV‐2 infection in a highly vaccinated population from the US National Basketball Association
Caroline G. Tai, Miriam J. Haviland, Stephen M. Kissler, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 2
Longitudinal Variations in Antibody Responses against SARS-CoV-2 Spike Epitopes upon Serial Vaccinations
Dicle Yalcin, Sydney J. Bennett, Jared Sheehan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7292-7292
Open Access | Times Cited: 7
Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial
Holly E. Baum, Russell Thirard, Alice Halliday, et al.
Vaccine (2024) Vol. 42, Iss. 12, pp. 2945-2950
Closed Access | Times Cited: 1
Genetic and epigenetic analyses of IFN-γ gene proximal promoter region underlying positive correlation between persistently high anti-SARS-CoV-2 IgG and IFN-γ among COVID-19 vaccinated Bangladeshi adults
Anika Tahsin, Piyash Bhattacharjee, Abdullah Al Saba, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126157-126157
Closed Access | Times Cited: 1
Spike and nucleocapsid antibody dynamics following SARS‐CoV‐2 infection and vaccination: Implications for sourcing COVID‐19 convalescent plasma from routinely collected blood donations
Clara Di Germanio, Xutao Deng, Brendan G. Balasko, et al.
Transfusion (2024) Vol. 64, Iss. 11, pp. 2063-2074
Open Access | Times Cited: 1
Optimal vaccination policy to prevent endemicity: a stochastic model
Félix Foutel‐Rodier, Arthur Charpentier, Hélène Guérin
Journal of Mathematical Biology (2024) Vol. 90, Iss. 1
Open Access | Times Cited: 1
Cohort Profile: Virus Watch—understanding community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviour
Thomas Byrne, Jana Kovar, Sarah Beale, et al.
International Journal of Epidemiology (2023) Vol. 52, Iss. 5, pp. e263-e272
Open Access | Times Cited: 4
Kinetics of Humoral Immunity against SARS-CoV-2 in Healthcare Workers after the Third Dose of BNT162b2 mRNA Vaccine
Tiziana Grassi, Giambattista Lobreglio, Alessandra Panìco, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1948-1948
Open Access | Times Cited: 6
Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
Letícia Carrijo Masson, Carolina do Prado Servian, Vitor Hugo Jardim, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1183-1183
Open Access | Times Cited: 2
Overview of the cardio-metabolic impact of the COVID-19 pandemic
Maryam Barkhordarian, Arezoo Behbood, Maryam Ranjbar, et al.
Endocrine (2023) Vol. 80, Iss. 3, pp. 477-490
Open Access | Times Cited: 2
A Probabilistic Description of the Impact of Vaccine-Induced Immunity in the Dynamics of COVID-19 Transmission
Javier Blecua, Juan Fernández‐Recio, José Manuel Gutiérrez
Open Journal of Modelling and Simulation (2024) Vol. 12, Iss. 02, pp. 59-73
Open Access
Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorder
Katlyn Nemani, Livia De Picker, Faith Dickerson, et al.
Brain Behavior & Immunity - Health (2024) Vol. 38, pp. 100802-100802
Open Access
Hybrid adaptive immunity to SARS-CoV-2 protects against breakthrough infection after COVID-19 vaccination in ALSPAC participants.
Holly E. Baum, Marianna Santopaolo, Ore Francis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The timing of local SARS-Cov-2 outbreaks and vaccination coverage during the Delta wave in Melbourne
Mehr Gupta, Kat Bogatyreva, Kiran Pienaar, et al.
Australian and New Zealand Journal of Public Health (2024) Vol. 48, Iss. 4, pp. 100164-100164
Open Access
SARS-CoV-2 Antibody Level after Homologous and Heterologous Booster Vaccines: an 18-month Longitudinal Observational Cohort Study in Indonesia
Tonang Dwi Ardyanto, Khariri, Telly Purnamasari Agus, et al.
The Open Public Health Journal (2024) Vol. 17, Iss. 1
Open Access
Evaluation of inflammatory biomarkers and their association with anti-SARS-CoV-2 antibody titers in healthcare workers vaccinated with BNT162B2
Ester Leno‐Durán, Esther Serrano‐Conde, Ana Salas-Rodríguez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial Insights
Sophie O’Reilly, Joanne Byrne, Eoin R. Feeney, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1089-1089
Open Access
Anti-RBD IgG dynamics following infection or vaccination
Amira Harrache, Kahina Saker, Bouchra Mokdad, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126464-126464
Open Access
Page 1 - Next Page

Scroll to top